SNDX
Syndax Pharmaceuticals, Inc. · Healthcare
CEO Michael A Metzger sold $411K of Syndax Pharmaceuticals, Inc.
Sold$410,508
$25.29Price
16,231Shares
−48%Stake
What SNDX did after the filing
- The stock from Fri, Oct 7 close, $24.22
- −8.7%
- S&P 500, same days
- +9.2%
Measured over 30 trading days, to the Nov 18 close.
Traded Thu, Oct 6. Filed Fri, Oct 7, 12:05 PM ET, during the session. Returns use the Oct 7 close and the Nov 18 close. Not investment advice.